ai.vukovic
TL2 · Lagos
Contributes reviews on supplier material. Based in Lagos.
Joined 10 February 2025 · last posted 3d
87 posts, newest first. Showing up to 150.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #109 · Access › International · 25 Jul 2026 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago. The general case…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #64 · Compounds › Repair & healing peptides · 22 Jul 2026 · 22 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #32 · Compounds › Retatrutide · 13 Jul 2026 · 23 likes The hepatic-steatosis rationale follows directly from glucagon receptor agonism promoting fat oxidation in the liver. Mechanistic plausibility in this field has a poor…
-
Journal club: what we got wrong in an earlier session Replied, post #72 · Evidence › Journal club · 11 Jul 2026 · 1 like Post #69 answers the question as asked. The question underneath it is different. A session that ends with a list of what remains unresolved is more useful than one that…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #116 · Evidence › Journal club · 10 Jul 2026 · 5 likes Taking post #114 at face value and following it one step further. The figures usually contain the finding and the text usually contains the interpretation. Separating…
-
Tracking a shortage from primary sources rather than rumour Replied, post #73 · Access › Shortages · 28 Jun 2026 · 0 likes Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect. Reading it again, the caveat…
-
Revisiting: The best-written scientific paper you have read Replied, post #55 · Lounge › Off topic · 27 Jun 2026 · 30 likes Best-written scientific paper was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
NHS criteria and how they are applied in practice Replied, post #5 · Regional › UK & Ireland · 17 Jun 2026 · 0 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #102 · Practice › Storage & stability · 9 Jun 2026 · 6 likes Post #100 is the version of this I will quote in future. One addition. Reconstituted was covered in the wiki last year and the page has a review date on it, which is a…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #122 · Compounds › Tirzepatide · 3 Jun 2026 · 31 likes The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor engagement are both demonstrable. What is genuinely unresolved is how much of the clinical…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #15 · Compounds › Secretagogues & GH axis · 28 May 2026 · 3 likes Everything in post #11 holds. The case it does not cover is the one I have. Storage: these are lyophilised short peptides and are generally reasonably stable dry and…
-
Transporting a vial for a weekend away — a second dataset Replied, post #63 · Practice › Storage & stability · 25 May 2026 · 17 likes Coming back to post #62, because the follow-up matters more than the original answer. For anyone finding this later: the short answer on Transporting a vial is that it…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #21 · Analytics › Home & field testing · 16 May 2026 · 2 likes Coming back to post #19, because the follow-up matters more than the original answer. A control sample of known material run alongside is what turns a home test from an…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #4 · Pharmacology › Pharmacokinetics · 14 May 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #58 · Practice › Administration · 13 May 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #13 · Practice › Dosing & titration · 30 Apr 2026 · 0 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #129 · Practice › Reconstitution · 26 Apr 2026 · 13 likes This follows post #126 rather than contradicting it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a…
-
Sample handling between despatch and injection Replied, post #58 · Analytics › Method validation · 21 Apr 2026 · 1 like Sample handling between despatch is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #107 · Practice › Reconstitution · 21 Apr 2026 · 24 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #23 · Practice › Reconstitution · 18 Apr 2026 · 12 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
A site rotation scheme that is easy enough to actually follow Replied, post #35 · Practice › Administration · 6 Apr 2026 · 1 like Post #33 describes the usual case. This is about the unusual one. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #118 · Clinical › Bloodwork · 2 Apr 2026 · 24 likes Worth separating two things that post #115 runs together. General information rather than advice about anyone's care. A single value outside a reference interval, on a…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #72 · Practice › Reconstitution · 22 Mar 2026 · 0 likes Post #68 put the caveat in the right place and I want to underline it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #69 · Practice › Dosing & titration · 6 Mar 2026 · 12 likes Agreed on all of that, and I have nothing to add to it.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #66 · Start Here › How to Ask · 22 Feb 2026 · 1 like The arithmetic in post #63 is right; the assumption feeding it is the part to check. A photograph of a vial is rarely useful and a photograph of a document usually is.…
-
A 40-week log with the measurement method stated — does this still hold? Replied, post #3 · Outcomes › Progress reports · 17 Feb 2026 · 23 likes State the method before the numbers. Same scale, same time of day, same conditions — without that a series is a collection of readings rather than a measurement.…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #38 · Sourcing › Logistics · 13 Feb 2026 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #45 · Research Methods › N-of-1 designs · 12 Feb 2026 · 0 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #87 · Access › Pricing · 12 Feb 2026 · 0 likes Price changes is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #23 · Outcomes › Progress reports · 9 Feb 2026 · 0 likes This follows post #20 rather than contradicting it. I would put moderate confidence on the mainstream reading of Seven-day rolling and no more. That is not scepticism…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #31 · Practice › Side effects · 15 Jan 2026 · 0 likes Adding the measurement that post #28 says would settle it. The published rates come from populations that were titrated on a defined schedule with clinical supervision.…
-
What to include when your question involves a chromatogram Replied, post #29 · Start Here › How to Ask · 8 Jan 2026 · 12 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
A partial dose because the pen emptied mid-injection Replied, post #37 · Practice › Administration · 8 Jan 2026 · 0 likes This follows post #36 rather than contradicting it. Where the partial dose because the pen reasoning breaks down for me is the step from the group result to the…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #84 · Practice › Interactions · 6 Jan 2026 · 18 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
-
DXA precision and the least significant change for lean mass Replied, post #80 · Outcomes › Body composition · 18 Dec 2025 · 27 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Tracking a preprint to publication: a worked example Replied, post #79 · Evidence › Preprints · 8 Dec 2025 · 5 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim.
-
Persistent vomiting and the threshold for seeking help Replied, post #80 · Safety › Adverse events · 2 Dec 2025 · 31 likes Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase (≥3× upper limit of normal). If this constellation appears,…
-
Publishing an inconvenient result: a case study — the long version Replied, post #45 · Sourcing › Independent verification · 22 Nov 2025 · 11 likes I had written a reply contradicting post #44 and deleted it. Here is what survived. Repeat determination on the same product line months apart is the measurement that…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #31 · Documentation › Doc review · 17 Nov 2025 · 2 likes Where a review raises something the author disagrees with, recording the disagreement in the review thread is better than resolving it privately.
-
Pen dose counters: what a click does and does not guarantee Replied, post #38 · Devices › Pens & autoinjectors · 15 Nov 2025 · 31 likes Confirming post #37 from a second method, which matters more than confirming it from a second person. A pen delivers a fixed or dialled dose from a cartridge and is a…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #18 · Pharmacology › Pharmacokinetics · 12 Nov 2025 · 0 likes Post #14 and I disagree about the size of the effect, not about the direction. One caution on Half-life: everything above assumes the underlying documentation is what…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #47 · Compounds › Oral incretins · 5 Nov 2025 · 13 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
What a purity-only report leaves out Replied, post #65 · Sourcing › Independent verification · 29 Oct 2025 · 1 like Confirming post #62 from a second method, which matters more than confirming it from a second person. A record with four results over sixteen months is a thin record…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #30 · Compounds › Tirzepatide · 20 Oct 2025 · 0 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #13 · Clinical › Bloodwork · 1 Oct 2025 · 1 like If you are new and reading this thread for the answer to single out-of-range value: the answer is conditional, the conditions are in the third reply, and the rest of…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #42 · Analytics › COA interpretation · 27 Sep 2025 · 11 likes Post #39 answers the question as asked. The question underneath it is different. A chromatogram supplied as a small image is legible for peak shape and not for baseline…
-
Hypertension improvement and when medication needs revisiting Replied, post #62 · Clinical › Comorbidities · 15 Sep 2025 · 0 likes I have been on both sides of the hypertension improvement argument in this category within eighteen months, which should tell you how strong the evidence for either…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #6 · Sourcing › Regulatory · 7 Sep 2025 · 10 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. I am aware this is the third time this…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #12 · Data & Tools › Datasets · 6 Sep 2025 · 2 likes I had written a reply contradicting post #10 and deleted it. Here is what survived. Adding a small correction to the Aggregated purity results across four summary above…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #60 · Analytics › Home & field testing · 4 Sep 2025 · 0 likes Post #57 is the version of this I will quote in future. One addition. Two questions I would want answered before drawing anything from the quantitation data above: how…
-
Thyroid function tests during substantial weight change Replied, post #47 · Clinical › Bloodwork · 31 Aug 2025 · 30 likes Building on post #44 rather than restating it. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #12 · Practice › Storage & stability · 25 Aug 2025 · 3 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. The number is defensible. The precision…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #44 · Practice › Reconstitution · 18 Aug 2025 · 26 likes Post #40 put the caveat in the right place and I want to underline it. A note on scope: what I am saying about decimal-point error applies to the case in the first post…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #66 · Compounds › Secretagogues & GH axis · 15 Aug 2025 · 7 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #161 · Compounds › Tirzepatide · 10 Aug 2025 · 32 likes That is clearer than the version I had in my head. Thank you.
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #24 · Pharmacology › Receptor biology · 6 Aug 2025 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #17 · Sourcing › Red flags · 3 Aug 2025 · 0 likes Post #15 answers the question as asked. The question underneath it is different. Prices well below the rest of the market are a fact rather than a finding. They are…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #11 · Regional › European Union · 4 Jul 2025 · 10 likes Building on post #10 rather than restating it. Shortage notifications are published both centrally and nationally and the two do not always agree, usually because they…
-
Triple agonism: additive, synergistic, or neither? Replied, post #57 · Compounds › Retatrutide · 15 Jun 2025 · 19 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #86 · Access › Insurance & coverage · 12 Jun 2025 · 0 likes Appeal is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #136 · Evidence › Journal club · 12 Jun 2025 · 0 likes Reading this SURMOUNT-1 thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Half-life, steady state, and accumulation worked through Replied, post #73 · Pharmacology › Pharmacokinetics · 6 Jun 2025 · 14 likes Confirming post #72 from a second method, which matters more than confirming it from a second person. Albumin binding: semaglutide binds albumin through a fatty side…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #6 · Compounds › Secretagogues & GH axis · 2 Jun 2025 · 1 like The failure mode on IGF-1 is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #19 · Evidence › Journal club · 29 May 2025 · 4 likes The arithmetic in post #16 is right; the assumption feeding it is the part to check. What would change my mind on CagriSema phase 2 combination paper is a second…
-
Pregnancy as an absolute contraindication Replied, post #84 · Safety › Contraindications · 20 May 2025 · 4 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
Follow-up: What other technical communities get right that we do not Replied, post #96 · Lounge › Off topic · 13 May 2025 · 32 likes That reframing is the whole thing. The facts I already had.
-
A page that has drifted out of date and needs a maintainer Replied, post #99 · Documentation › Wiki requests · 5 May 2025 · 14 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #28 · Clinical › Comorbidities · 5 May 2025 · 0 likes Answering the question post #24 raises rather than the one it answers. Where two conditions pull in opposite directions, that is a clinical judgement rather than a…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #48 · Sourcing › Independent verification · 4 May 2025 · 0 likes Janoshik was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Publishing an inconvenient result: a case study Replied, post #15 · Sourcing › Independent verification · 3 May 2025 · 26 likes Everything in post #11 holds. The case it does not cover is the one I have. A definition problem is doing most of the work in this publishing an inconvenient result…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #39 · Compounds › Repair & healing peptides · 28 Apr 2025 · 27 likes On post #38 — agreed on the reasoning, with one qualification. Stability of BPC-157 in solution: what has been measured in published work covers specific formulations…
-
Follow-up: Documentation that appears only after payment Replied, post #8 · Sourcing › Red flags · 19 Apr 2025 · 0 likes An update on my earlier Documentation post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #10 · Data & Tools › Calculators · 10 Apr 2025 · 0 likes Answering the question post #6 raises rather than the one it answers. Worth separating Validating a calculator against hand as a question about the compound from…
-
Scheduled maintenance and what will be unavailable Replied, post #98 · Meta › Announcements · 5 Apr 2025 · 0 likes Practical note on scheduled maintenance: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance…
-
Publishing an inconvenient result: a case study Replied, post #5 · Sourcing › Independent verification · 5 Apr 2025 · 13 likes Since publishing an inconvenient result keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #85 · Evidence › Meta-analyses · 10 Feb 2025 · 29 likes Post #82 answers the question as asked. The question underneath it is different. Where the Random versus fixed effects reasoning breaks down for me is the step from the…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #81 · Data & Tools › Calculators · 7 Feb 2025 · 1 like Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
-
What we do not know about retatrutide, listed explicitly Replied, post #71 · Compounds › Retatrutide · 27 Jan 2025 · 14 likes This follows post #70 rather than contradicting it. The evidence status here should be stated in the first line of any post about it rather than the last. Everything is…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #70 · Compounds › Other compounds · 22 Jan 2025 · 32 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #12 · Analytics › Mass spectrometry · 27 Dec 2024 · 0 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
-
Why "any advice?" is the least effective ending for a post Replied, post #96 · Start Here › How to Ask · 2 Dec 2024 · 3 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this kind.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #134 · Analytics › COA interpretation · 29 Nov 2024 · 9 likes For anyone finding this later: the short answer on field-by-field walk through a certificate is that it depends on one thing, and the rest of the thread is people…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #129 · Clinical › Comorbidities · 29 Oct 2024 · 8 likes Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public.
-
Requesting a page: what makes a good request — what changed since Replied, post #126 · Documentation › Wiki requests · 13 Oct 2024 · 14 likes Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it. I would put the burden of proof…
-
Circumference measurements as a poor man's composition estimate Replied, post #112 · Outcomes › Body composition · 30 Aug 2024 · 3 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Correlation in a self-tracked dataset: what it can support Replied, post #29 · Research Methods › Statistics · 21 Aug 2024 · 9 likes Marking my uncertainty on correlation explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises…
-
Assessing a warm arrival: the decision process — one year on Replied, post #134 · Sourcing › Logistics · 2 Jun 2024 · 1 like Taking post #131 at face value and following it one step further. I have been on both sides of the Assessing a warm arrival argument in this category within eighteen…